Vancomycin removal during high-volume peritoneal dialysis in acute kidney injury patients
Nenhuma Miniatura disponível
Data
2019-03-01
Autores
Ponce, Daniela [UNESP]
Zamoner, Welder [UNESP]
Freitas, Fernanda Moreira [UNESP]
Balbi, André [UNESP]
Awdishu, Linda
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Studies on vancomycin pharmacokinetics in acute kidney injury (AKI) patients on high-volume peritoneal dialysis (HVPD) are lacking. We studied the pharmacokinetics of intravenous (IV) vancomycin in AKI patients treated by HVPD who received a prescribed single IV dose of vancomycin (15 – 20 mg/kg total body weight) to determine the extent of vancomycin removal and to establish vancomycin dosing guidelines for the empirical treatment of AKI patients receiving HVPD. The application of 18 mg/kg vancomycin every 48 – 72 hours in AKI patients undergoing HVPD was required to maintain therapeutic concentrations.
Descrição
Palavras-chave
AKI, sepsis
Como citar
Peritoneal Dialysis International, v. 39, n. 2, p. 183-187, 2019.